AUGUSTA (AP) — Maine is getting $950,000 from EpiPen maker Mylan as part of a national settlement.
The company this week finalized a $465 million federal agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade.
Maine Attorney General Janet Mills called the company’s conduct “unconscionable.”
It’s the second settlement with the Department of Justice that Mylan has made since 2009 for allegedly overcharging the government.
The new case involves Mylan paying Medicaid too-low rebates for the devices by classifying its brand-name product as a generic, which requires lower rebates.
Those actions are separate from another lawsuit Maine filed against Mylan for alleged price-fixing for a certain diabetes medication and an antibiotic. That lawsuit is pendi
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less